Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #855

    The IND was for RA. Rheumatoid Arthritis.

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #856

      Oh really? thanks. they had one submitted in August for RA also.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #857

        Its the same

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #858

          ok. understood. I know at the time they said they would file another IND before the end of the year, i cant remember what that would be for, i wrongly thought he was referring to that

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #859

            That was the hexa- and duobody compounds. Slides 16 and 17.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #860

              Mærkeligt nok synes jeg ikke han nævnte den Tv-combo i frontline cervical, som fremgik af R&D præsentationen?

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #861

                Næh. Omkring TV sagde han 2. og 3. linie.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #862

                  Jeg spør ham på q&a

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #863

                    indeed, it actually says on p16 IND & CTAs filed in Q4 for DR5/DR5... i am a bit slow this morning ;-(

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Parasitism
                      wrote on sidst redigeret af
                      #864

                      You need a cup of Cirkel kaffe

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #865

                        😉

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #866

                          Jeg noterede mig at han ikke var bekymret for effektiviteten i DR5/DR5. Sikkerheden var det vigtigste udestående. De ville starte et studie "very soon" og allerede senere i år ville vi få de første sikkerhedsdata.

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JohnW
                            wrote on sidst redigeret af
                            #867

                            Er dagens kursfald en reaktion på Jans præsentation i går?

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              polle1
                              wrote on sidst redigeret af
                              #868

                              Hvorfor skulle det være det, JohnW ?

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #869

                                Det samme for cd3xcd20. Måske sikkerhedsdata senere i år.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #870

                                  Link Preview Image
                                  Norsk kræftselskab viser lovende data på Genmab-område

                                  Norske Bergenbio, der ligesom danske Genmab udvikler et lægemiddel rettet mod proteinet AXL, har vist positive effektdata for sin kandidat inden for behandling af lungekræft i kombination med et ældre lægemiddel fra Roche.

                                  favicon

                                  (medwatch.dk)

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #871

                                    Det kunne måske være fordi han overhovedet ikke kom ind på dara-salget i 18. Han nævnte kun at det for 17 forventes at lande i øvre ende af estimatet.

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raffles
                                      wrote on sidst redigeret af
                                      #872

                                      Vedr. JNJ-63723283 phase I study. Actual study start var Nov 2017 og Estimated Primary Completion date er March 2018. Der er 386 patienter! Det er da en ekstrem hurtig indrullering (NCT 03357952). Kan det virkelig lade sig gøre ??

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #873

                                        JP Morgan er en af de steder, hvor biotek indimellem ynder at smide en nyhed - det kom der ikke rigtig fra Genmab, så måske en lille skuffelse i markedet efter den flotte stigning

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #874

                                          Bears have pulled this same trick for 3months now; after ANY event, specially overnight which nobody has seen yet, just dump a few thousand shares in the morning and the negative tone is set...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger